Cargando…

Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market

BACKGROUND: Our study estimated insurance payments and patient out-of-pocket (OOP) expenses associated with discarded weight-based intravenous antineoplastic drugs for privately insured US adult patients with cancer. METHODS: We identified patients who received weight-based antineoplastic drugs from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shih, Ya-Chen Tina, Xu, Ying, Zhao, Hui, Schrag, Deborah, Yao, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328094/ https://www.ncbi.nlm.nih.gov/pubmed/34350376 http://dx.doi.org/10.1093/jncics/pkab045

Ejemplares similares

Financial Outcomes of “Bagging” Oncology Drugs Among Privately Insured Patients With Cancer
por: Shih, Ya-Chen Tina, et al.
Publicado: (2023)

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs
por: Layton, Jodi L., et al.
Publicado: (2018)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs
por: Chambers, James D., et al.
Publicado: (2016)

Financial burden imposed on the insured patients for private treatment: Evidence from a state of Iran
por: Etemadi, Manal, et al.
Publicado: (2019)

Financial Knowledge and Private Health Insurance: Does Age Matter?
por: Aguiar-Díaz, Inmaculada, et al.
Publicado: (2023)

How do Medicare Physician Fees Compare With Private Payers?
por: Miller, Mark E., et al.
Publicado: (1993)

Variability in Private Payer Medical Policies for Osteochondral Allograft Transplantation Demonstrates the Absence of Standardization in Medical Criteria Between Payers
por: Tabbaa, Suzanne M., et al.
Publicado: (2022)

Private Health Insurance Plans in 1977: Coverage, Enrollment, and Financial Experience
por: Carroll, Marjorie Smith, et al.
Publicado: (1979)

Actuarial Analysis of Private Payer Administrative Claims Data for Women With Endometriosis
por: Mirkin, David, et al.
Publicado: (2007)

Specialty Pharmacy Cost Management Strategies of Private Health Care Payers
por: Stern, Debbi, et al.
Publicado: (2006)

Implementation of Shared Decision Making for Lung Cancer Screening Among the Privately Insured Nonelderly
por: Shih, Ya-Chen Tina, et al.
Publicado: (2021)

To discard or not to discard: transplantation and the art of scoring
por: Stallone, Giovanni, et al.
Publicado: (2019)

Should Insurers Pay the Same Fees Under an All-Payer System?
por: Kominski, Gerald F., et al.
Publicado: (1994)

Abstract 101: Impact Of Insurance Payer On Type Of Breast Reconstruction Performed
por: Gabrick, Kyle, et al.
Publicado: (2019)

Hemodialysis Versus Peritoneal Dialysis Drug Expenditures: A Comparison Within the Private Insurance Market
por: Bhatnagar, Anshul, et al.
Publicado: (2023)

Private Payer Coverage Policies for ApoE-e4 Genetic Testing
por: Arias, Jalayne J., et al.
Publicado: (2021)

Contagion modeling between the financial and insurance markets with time changed processes
por: Hainaut, Donatien
Publicado: (2017)

Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries
por: Wells, William A., et al.
Publicado: (2011)

Financial protection effects of private health insurance: experimental evidence from Chinese households with resident basic medical insurance
por: Fu, Xian-zhi
Publicado: (2021)

Comment on: “Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective”
por: Liedgens, Hiltrud, et al.
Publicado: (2013)

US public and private payer coverage for tobacco cessation treatments and barriers to accessing treatments
por: Hussain, Radha, et al.
Publicado: (2022)

Performance evaluation and analysis of Chinese insurance companies under uncertain financial markets
por: Jia-Ying, Jiang, et al.
Publicado: (2023)

Private Health Insurance Flans in 1978 and 1979: A Review of Coverage, Enrollment, and Financial Experience
por: Carroll, Marjorie Smith, et al.
Publicado: (1981)

The Financial Impact of Advanced Kidney Disease on Canada Pension Plan and Private Disability Insurance Costs
por: Manns, Braden, et al.
Publicado: (2017)

Private Health Insurance and Financial Risk Taking in Spain—The Moderating Effect of Subjective Risk Tolerance
por: Aguiar-Díaz, Inmaculada, et al.
Publicado: (2022)

Disparity in clinical outcomes after cardiac surgery between private and public (NHS) payers in England
por: Benedetto, Umberto, et al.
Publicado: (2020)

Application of Economic Analyses in U.S. Managed Care Formulary Decisions: A Private Payer's Experience
por: Watkins, John B., et al.
Publicado: (2006)

Effect of Insurance on Prescription Drug Use by ESRD Beneficiaries
por: Shih, Ya-chen Tina
Publicado: (1999)

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
por: Sikirica, Mirko, et al.
Publicado: (2014)

The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States
por: Saxena, Kunal, et al.
Publicado: (2023)

Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
por: Zhdanava, Maryia, et al.
Publicado: (2020)

Financial risk in insurance
por: Ottaviani, G
Publicado: (2000)

Financial and Insurance Formulas
por: Cipra, Tomas
Publicado: (2010)

Trends in Shoulder Stabilization Techniques Used in the United States Based on a Large Private-Payer Database
por: Riff, Andrew J., et al.
Publicado: (2017)

Very high and low residual spenders in private health insurance markets: Germany, The Netherlands and the U.S. Marketplaces
por: McGuire, Thomas G., et al.
Publicado: (2020)

Estimating the Size of Illicit Tobacco Market in Lithuania: Results from the Discarded Pack Collection Method
por: Liutkutė-Gumarov, Vaida, et al.
Publicado: (2023)

Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990)

Are payers treating orphan drugs differently?
por: Cohen, Joshua P., et al.
Publicado: (2014)

Healthcare resource use and cost burden of urinary incontinence to United States payers
por: Datar, Manasi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5ob7jr8gethfe5nhte83n6taq